Form 4: Establishment Labs Holdings CEO Acquires Stock Units and Options

CEO Filippo Caldini receives stock units and options in Establishment Labs Holdings Inc.

Summary

• Filippo Caldini, CEO of Establishment Labs Holdings Inc., reported changes in beneficial ownership.
• On May 14, 2025, Caldini acquired 6,856 common shares and 12,009 stock options.
• The common shares were awarded as stock units under the Issuer's 2018 Equity Incentive Plan.
• One-fourth of the shares subject to the award will vest on May 7, 2026, and annually thereafter, contingent on continued service.
• The stock options have an exercise price of $36.46 and expire on May 14, 2035.
• One-fourth of the shares subject to the option will vest on May 7, 2026, and annually thereafter, contingent on continued service.
• Following the transaction, Caldini beneficially owns 32,395 common shares and 12,009 stock options.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating confidence in the company's leadership and future prospects. The vesting schedule promotes long-term alignment, which is generally viewed positively.

Positives

• The award of stock units and options aligns the CEO's interests with those of the shareholders.
• The vesting schedule incentivizes long-term commitment from the CEO.

Risks

• The value of the stock units and options is dependent on the future performance of the company's stock.
• If the CEO leaves the company before the vesting dates, the unvested shares and options will be forfeited.

Future Outlook

The vesting schedule of the stock units and options suggests an expectation of continued service and commitment from the CEO.

Industry Context

This type of equity compensation is common for CEOs in publicly traded companies to align their interests with shareholders and incentivize long-term growth.

Comparison to Industry Standards

• Equity compensation packages for CEOs in the medical device industry typically include a mix of stock options and restricted stock units.
• Vesting schedules are often structured to incentivize long-term performance, with vesting periods ranging from three to five years.
• The specific terms of the equity compensation package, such as the number of shares and the exercise price of the options, are typically determined based on the CEO's experience, performance, and the company's overall financial performance.
• Comparable companies such as Sientra and Allergan also utilize similar equity compensation strategies for their executive teams.

Stakeholder Impact

• Shareholders may view the equity compensation as a positive sign, aligning management's interests with their own.
• Employees may be motivated by the CEO's commitment to the company's long-term success.

Key Dates

Keywords

Establishment Labs Holdings, ESTA, Filippo Caldini, Stock Options, Stock Units, Beneficial Ownership, Equity Incentive Plan, SEC Form 4